Redefining breast cancer: therapeutic opportunities in HER2-low and emerging molecular subtypes.

Saved in:
Bibliographic Details
Title: Redefining breast cancer: therapeutic opportunities in HER2-low and emerging molecular subtypes.
Authors: Shadab A; Faculty of Pharmacy, Integral University, Lucknow, 226026, India. abshadab@student.iul.ac.in., Al-Shdefat RIK; Faculty of Pharmacy, Jadara University, Irbid, Jordan.
Source: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2026 Jul 21. Date of Electronic Publication: 2026 Jul 21.
Publication Type: Journal Article; Review
Journal Info: Publisher: Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1699-3055
DOI:10.1007/s12094-026-04508-0